Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RCKT
Stock Latest News
The Fly
EMA says Rocket Pharmaceuticals withdraws MA application for Fanskya
2h ago
RCKT
Premium
Ratings
Hold Rating on Rocket Pharmaceuticals Amid Uncertainties in RP-A501 Study Resumption
11h ago
RCKT
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
1d ago
AMD
APM
Premium
Market News
Bank of America Upgrades Rocket Pharma Stock (RCKT) After FDA Lifts Clinical Hold on Danon Disease Trial
1d ago
RCKT
Premium
Ratings
Cautious Optimism for Rocket Pharmaceuticals Amid Adjusted RP-A501 Trial Protocol
1d ago
RCKT
Premium
Ratings
Rocket Pharmaceuticals’ RP-A501 Study Advances with FDA Approval and Enhanced Safety Measures, Justifying Buy Rating
2d ago
RCKT
Premium
The Fly
BofA upgrades Rocket Pharmaceuticals to Buy after clinical hold lifted
2d ago
RCKT
Premium
The Fly
Rocket Pharmaceuticals upgraded to Buy from Neutral at BofA
2d ago
RCKT
Premium
The Fly
Citi says FDA may take ‘more comprehensive look’ at Sarepta Elevidys adjustment
2d ago
RCKT
SRPT
Premium
The Fly
Target names CEO successor, Guess to go private: Morning Buzz
2d ago
BZ
EU
Premium
The Fly
Rocket alignment with FDA ‘sounds reasonable,’ says Chardan
2d ago
RCKT
Premium
Ratings
Cautious Optimism: Hold Rating on Rocket Pharmaceuticals Amid Resumed Phase II Study with Protocol Changes
2d ago
RCKT
Premium
The Fly
Morning Movers: Target sinks following Q2 earnings and CEO succession plan
2d ago
EL
ADI
Premium
Company Announcements
FDA Lifts Hold on Rocket’s Danon Disease Trial
2d ago
8K
RCKT
Premium
The Fly
Rocket Pharmaceuticals announces clinical hold lifted on RP-A501 trial
2d ago
RCKT
Premium
Ratings
Rocket Pharmaceuticals: Hold Rating Amid Clinical and Financial Uncertainties
11d ago
RCKT
Premium
Company Announcements
Rocket Pharma Reports Q2 2025 Financial Results
11d ago
RCKT
Premium
Ratings
Rocket Pharmaceuticals: Strategic Focus on AAV Gene Therapy and Financial Resilience Justifies Buy Rating
14d ago
RCKT
Premium
Ratings
Rocket Pharmaceuticals: Strategic Shift Amidst Clinical Challenges and Promising Pipeline Developments
14d ago
RCKT
Premium
Ratings
Cautious Hold Rating on Rocket Pharmaceuticals Amid Regulatory Challenges and Strategic Restructuring
14d ago
RCKT
Premium
Company Announcements
Rocket Pharmaceuticals Announces Strategic Restructuring and Leadership Changes
15d ago
8K
RCKT
Premium
The Fly
Rocket Pharmaceuticals reports Q2 EPS (62c), consensus (53c)
15d ago
RCKT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
